Netropsin binds selectively to AT-rich sequences in the minor groove of B-form DNA, protecting these regions from cleavage by DNase I and endonucleases, and inhibiting topoisomerase activity; it disrupts the cell division cycle by prolonging and arresting cells in the G phase; it exhibits antimicrobial activity against bacteria, fungi, trypanosomes, vaccinia virus, and bacteriophages; it competes with HMGA1 for binding to AT-rich DNA regions, thereby prolonging survival in endotoxemic mice; it suppresses invasion and metastasis of glioma cells via HMGA2 inhibition; and it reduces the invasive and metastatic potential of gastric cancer cells by inhibiting epithelial-mesenchymal transition (EMT).